China approves fourth COVID-19 vaccine for emergency use

AP — China has approved a new COVID-19 vaccine for emergency use, one that was developed by the Head of its Center for Disease Control and Prevention (CDC), adding to its arsenal.

China’s CDC head Gao Fu led the development of a protein subunit vaccine that was approved by regulators last week for emergency use, the Chinese Academy of Sciences’ Institute of Microbiology said in a statement on Monday.

It is the fourth such vaccine to be given emergency use approval. China has approved four vaccines developed by three Chinese companies for general use.

The vaccine was developed jointly by Anhui Zhifei Longcom Biopharmaceutical Co Ltd and the Chinese Academy of Sciences. The team finished phase one and phase two clinical trials last October and is currently conducting the last phase of trials in Uzbekistan, Pakistan and Indonesia, according to the statement.